Company Filing History:

13 out of 3,682

The Johns Hopkins University

4. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2003

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6573271 - Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists (2003-06-03),

2. 6372753 - Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists (2002-04-16),

3. 6309419 - Tympanic membrane prosthesis with mechanical fixation (2001-10-30),

4. 6092898 - Surgical contact lens, methods for viewing the interior of an eye and (2000-07-25),

5. 6075032 - Method of preventing proliferation of retinal pigment epithelium by (2000-06-13),

6. 6073759 - Pre-filled package containing unit dose of medical gas and method of (2000-06-13),

7. 6028099 - Use of an inhibitor of the protein tyrosine kinase pathway in the (2000-02-22),

8. 5997498 - Inline air humidifier, a system for humidifying air and methods related (1999-12-07),

9. 5993072 - Adapter assembly for connecting multiple optic fiber illuminated (1999-11-30),

10. 5980929 - Use of a protein tyrosine kinase pathway inhibitor in the treatment of (1999-11-09),

11. 5944747 - Method for preferential outer retinal stimulation (1999-08-31),

12. 5935155 - Visual prosthesis and method of using same (1999-08-10),

13. 5919813 - Use of a protein tyrosine kinase pathway inhibitor in the treatment of (1999-07-06),

14. 5563584 - Liquid level sensing and monitoring system for medical fluid infusion (1996-10-08),

15. 5554155 - Fiber optic pick manipulator (1996-09-10),

Title: Innovations of Eugene De Juan, Jr.

Introduction

Eugene De Juan, Jr. is a prominent inventor based in Phoenix, MD (US). He has made significant contributions to the field of ocular health, holding a total of 16 patents. His work primarily focuses on methods to prevent the proliferation of retinal pigment epithelium, which is crucial for treating various ocular diseases.

Latest Patents

One of his latest patents involves a method of preventing the proliferation of retinal pigment epithelium by using retinoic acid receptor agonists. This method addresses the proliferation of retinal pigment epithelium following surgery or trauma, as well as conditions associated with choroidal neovascularization, such as age-related macular degeneration and histoplasmosis syndrome. The invention details the use of a therapeutic amount of a retinoic acid receptor (RAR) agonist, which is preferably a potent antagonist of AP1-dependent gene expression. The drug can be administered through bolus injection into the vitreous cavity or by slow release from liposomes or an oil tamponade.

Career Highlights

Eugene De Juan, Jr. has had a distinguished career, working with notable institutions such as The Johns Hopkins University. His innovative approaches have led to advancements in the treatment of ocular diseases, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues, including R Scott Rader and Alexander C Walsh. These partnerships have further enhanced the impact of his inventions in the medical field.

Conclusion

Eugene De Juan, Jr. is a key figure in ocular innovation, with a focus on preventing retinal pigment epithelium proliferation. His contributions through patents and collaborations continue to shape the future of ocular health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.